Structural Basis for the Inhibition of Tyrosine Kinase Activity of ZAP-70

Sebastian Deindl(Uppsala University), John Kuriyan(Vanderbilt University), Theresa A. Kadlecek(Howard Hughes Medical Institute), Tomáš Brdička(Czech Academy of Sciences), Arthur Weiss(Howard Hughes Medical Institute), Xiaoxian Cao(QB3)

Cell

May 1, 2007

10.1016/j.cell.2007.03.039

Cited by 234

Related Papers

Crystallographic <i>R</i> Factor Refinement by Molecular Dynamics

|Science|1987|2k

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase

|Science|2000|1.8k

The Conformational Plasticity of Protein Kinases

|Cell|2002|1.8k

An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor

|Cell|2006|1.6k

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

|Cancer Cell|2002|1.6k